Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Angulo

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
The American Journal of Gastroenterology|February 11, 2010
Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort studyLeon A Adams, Scott Harmsen, Jennifer L St Sauver, et al.
Gastroenterology|July 14, 2005
The natural history of nonalcoholic fatty liver disease: a population-based cohort studyLeon A Adams, James F Lymp, Jenny St Sauver, et al.
The Annals of Pharmacotherapy|March 14, 2013
Risk factors for venous thromboembolism in patients with chronic liver diseaseKelly A Walsh, Daniel A Lewis, Timothy M Clifford, et al.
Journal of Gastroenterology and Hepatology|April 23, 2002
Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosisManuela Neuman, Paul Angulo, Izabella Malkiewicz, et al.
Hepatology (Baltimore, Md.)|September 22, 2005
Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trialClaudia O Zein, Roberta A Jorgensen, Bart Clarke, et al.
Hepatology (Baltimore, Md.)|January 29, 2008
Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver diseaseMichael Charlton, Paul Angulo, Naga Chalasani, et al.
Digestive Diseases and Sciences|February 12, 2002
Pirfenidone in the treatment of primary sclerosing cholangitisPaul Angulo, Robert L MacCarty, Pamela B Sylvestre, et al.
Hepatology (Baltimore, Md.)|June 10, 2008
Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trialValerio Nobili, Melania Manco, Rita Devito, et al.
Gastroenterology|July 18, 2013
Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver diseasePaul Angulo, Elisabetta Bugianesi, Einar S Bjornsson, et al.
Gastroenterology|October 13, 2006
Utility of a new model to diagnose an alcohol basis for steatohepatitisWinston Dunn, Paul Angulo, Schuyler Sanderson, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
The American Journal of Gastroenterology|February 11, 2010
Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort studyLeon A Adams, Scott Harmsen, Jennifer L St Sauver, et al.
Gastroenterology|July 14, 2005
The natural history of nonalcoholic fatty liver disease: a population-based cohort studyLeon A Adams, James F Lymp, Jenny St Sauver, et al.
The Annals of Pharmacotherapy|March 14, 2013
Risk factors for venous thromboembolism in patients with chronic liver diseaseKelly A Walsh, Daniel A Lewis, Timothy M Clifford, et al.
Journal of Gastroenterology and Hepatology|April 23, 2002
Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosisManuela Neuman, Paul Angulo, Izabella Malkiewicz, et al.
Hepatology (Baltimore, Md.)|September 22, 2005
Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trialClaudia O Zein, Roberta A Jorgensen, Bart Clarke, et al.
Hepatology (Baltimore, Md.)|January 29, 2008
Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver diseaseMichael Charlton, Paul Angulo, Naga Chalasani, et al.
Digestive Diseases and Sciences|February 12, 2002
Pirfenidone in the treatment of primary sclerosing cholangitisPaul Angulo, Robert L MacCarty, Pamela B Sylvestre, et al.
Hepatology (Baltimore, Md.)|June 10, 2008
Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trialValerio Nobili, Melania Manco, Rita Devito, et al.
Gastroenterology|July 18, 2013
Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver diseasePaul Angulo, Elisabetta Bugianesi, Einar S Bjornsson, et al.
Gastroenterology|October 13, 2006
Utility of a new model to diagnose an alcohol basis for steatohepatitisWinston Dunn, Paul Angulo, Schuyler Sanderson, et al.
Pageof 12